¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Dalton Trans"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dalton
    µ¹ÅÏ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • trans
    °æ-, °æÀ¯-, Åë°ú-
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • trans
    °æ-, °æÀ¯-, Åë°ú-
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Dalton
    ´ÞÅæ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cis-trans test
    ½Ã½º-Æ®·£½º°Ë»ç
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dalton
    µ¹Åæ[Ó¤êÈ]
  • cis-trans isomers
    ½Ã½ºÆ®¶õ½º À̼ºÃ¼(ì¶àõô÷)
  • cis-trans test
    ½Ã½ºÆ®¶õ½º ½ÃÇè(ãËúÐ)
  • trans
    Æ®¶õ½º
  • trans-acting locus
    Æ®¶õ½ºÀÛ¿ëºÎÀ§ (íÂéÄÝ»êÈ)
  • trans effect
    Æ®¶õ½º È¿°ú(üùÍý)
  • TRANS-IF
    (å²) transient state isoelectric focusing
  • trans isomer
    Æ®¶õ½ºÀ̼ºÃ¼(ì¶àõô÷)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
1.4 Kbp = 1 M Dalton
Da dalton
Dal, dal dalton
OTC Ornithine Trans-Carbamylase
PTHC Percutaneous Trans-Hepatic Cholangiography(-gram)
  = PTC
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ALL-Trans RA ALL-Trans Retinoic acid
tt-MA Trans, trans-muconic acid
trans-ACPD Trans-1-amino-1,3-cyclopentanedicarboxylic acid
kDa killo-dalton
Da Dalton
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 31991
    JournalTitle: 2003)
    MedAbbr: Dalton Trans
    ISSN: 1477-9226
    ESSN:
    IsoAbbr:
    NlmId: 101176026
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Dalton
    ´ÞÅæ, Áú·®ÀÇ ´ÜÀ§
    ºÐÀÚ·®ÀÇ Ç¥½Ã¿¡ »ç¿ëµÇ´Â ´ÜÀ§, »ê¼Ò 1 ¿øÀÚ·®ÀÇ 1/16, Áï 1, 650*10
  • { ¥Ä}^{ 1}

    -3,4-trans[

    { ¥Ä}^{9 }

    -THC Ȥ
    ´ë¸¶ °ü·Ã Àå¾Ö, ´ë¸¶ °ü·Ã º´
  • cis-trans
    ½Ã½º-Æ®¶õ½º ½ÃÇè
    ¹Ì»ý¹° À¯ÀüÇп¡¼­, µ¿ÀÏÇÑ Ç¥ÇöÇü È¿°ú¸¦ °®´Â µÎ °¡Áö µ¹¿¬º¯À̰¡ µ¿ÀÏÇÑ À¯ÀüÀÚ³»¿¡ Á¸ÀçÇÏ´ÂÁö ¶Ç´Â ´Ù¸¥ À¯ÀüÀÚ¿¡ Á¸ÀçÇÏ´ÂÁö¸¦ ÆÇÁ¤ÇÏ´Â ½ÃÇè.
  • trans urethral resection
    °æ¿äµµÀû Àü±â ÀýÁ¦¼ú
    Àü¸³¼± ºñ´ëÁõÀ̳ª ¹æ±¤Áõ µîÀ» °³º¹ÇÏÁö ¾Ê°í ¿äµµ¸¦ ÅëÇØ¼­ ³»½Ã°æÀûÀ¸·Î ÀýÁ¦ÇÏ´Â ¼ö¼ú ¹æ¹ý. ¸ÕÀú ¹æ±¤ ¿äµµ¿ë ÆÄÀ̹ö½ºÄÚÇÁ¿¡ ¼ö¼ú¿ë ÀåÄ¡°¡ ´Þ¸° ³»°æ 8~9 mmÀÇ °¡´À´Ù¶õ ÀýÁ¦°æ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
dalton <unit> A unit of mass that equals the weight of a hydrogen atom, or 1.657 x10-24 grams.
Named for John Dalton, an early nineteenth century British chemist who proposed the atomic theory of matter.
(09 Oct 1997)
Dalton-Henry law In dissolving a mixture of gases, a liquid will absorb as much of each gas in the mixture as if that were the only gas dissolved.
(05 Mar 2000)
Dalton, John <person>English chemist, mathematician, and natural philosopher, 1766-1844.
See: Dalton's law, Dalton-Henry law, daltonian, daltonism.
(05 Mar 2000)
Dalton's law Each gas in a mixture of gases exerts a pressure proportionate to the percentage of the gas and independent of the presence of the other gases present.
Synonym: law of partial pressures.
(05 Mar 2000)
all-trans-retinal The orange retinaldehyde resulting from the action of light on the rhodopsin of the retina, which converts the 11-cis-retinal component of the rhodopsin to all-trans-retinal plus opsin.
Synonym: trans-retinal, visual yellow.
(05 Mar 2000)
peptidyl prolyl cis trans isomerase See: PPIase and immunophilin.
(18 Nov 1997)
cis-9,trans-11-octadecadienoate reductase <enzyme> Uses NADH and alpha-tocopherol quinol; forms trans-11-octadecenoate
Registry number: EC 1.3.1.-
Synonym: 9,11-ocdd reductase
(26 Jun 1999)
cis-trans-isomerases <enzyme> Enzymes that catalyze the rearrangement of geometry about double bonds.
Registry number: EC 5.2
(12 Dec 1998)
cis trans test <molecular biology> The complementation test with two or more interacting genes placed in cis and in trans relationships to each other. A double mutant genome is used in the cis test made from the two single mutant genomes used in the trans test by recombination.
If the wild type phenotype is restored by both cis and trans arrangements it is concluded that the two mutations are in different genes and hence that the phenotype is determined by more than one gene. If the trans test is negative and the cis positive this means that the two mutations are in the same gene. If both tests are negative then at least one of the mutations must be dominant. Thus the double test provides a means of fine mapping of genes.
A lab test which is used to determine whether two mutations of different genes which affect the same phenotype are on the same functional unit (indicating a cis configuration of the mutated genes) or on different functional units (indicating a trans configuration of the mutated genes). (A functional unit can be a chromosome.)
The test is done by mating an individual that has one of the mutations to an individual that has the other one, and observing whether their offspring have the mutant phenotype. If the offspring do not have the mutant phenotype, then the genes are known to be trans, because the offspring have normal copies of each mutant gene on the different functional units which are able to genetically complement each other. If the offspring do have the mutant phenotype, then the genes are known to be cis, because the offspring will always inherit at least one of the mutant genes on the one functional unit, resulting in the mutant phenotype.
(09 Oct 1997)
trans- 1. Prefix denoting across, through, beyond; opposite of cis-.
2. In genetics, denoting the location of two genes on opposite chromosomes of a homologous pair.
3. In organic chemistry, a form of geometric isomerism in which the atoms attached to two carbon atoms, joined by double bonds, are located on opposite sides of the molecule.
4. In biochemistry, a prefix to a group name in an enzyme name or a reaction denoting transfer of that group from one compound to another; e.g., transformylase (transfers a formyl group), transpeptidation.
Origin: L. Trans, through, across
(05 Mar 2000)
trans-1,2-dihydrobenzene-1,2-diol dehydrogenase <enzyme> Rat liver cytosol enzyme also catalyses 3alpha-hydroxysteroid dehydrogenase activity (EC 1.1.1.50); bphb isolated from pseudomonas
Registry number: EC 1.3.1.20
Synonym: acenaphthenol oxidase, dihydrodiol dehydrogenase, bphb gene product, biphenyl-2,3-dihydrodiol-2,3-dehydrogenase
(26 Jun 1999)
trans-2-hydroxybenzylidenepyruvate hydratase-aldolase <enzyme> Catalyses the hydration of cis-o-hydroxybenzylidenepyruvate with subsequent cleavage to form salicylaldehyde--important steps in the bacterial degradation of naphthalene to salicylate
Registry number: EC 4.2.1.-
Synonym: trans-o-hydroxybenzylidenepyruvate hydratase-aldolase, thbpa hydratase-aldolase
(26 Jun 1999)
trans-3-chloroacrylic acid dehalogenase <enzyme> Specific for conversion of trans-3-chloroacrylic acid to muconic saemialdehyde (3-oxopropionic acid); 34 amino-terminal amino acid sequence, with 3 questionable aas, given in first source
Registry number: EC 3.8.1.-
Synonym: trans-3caa dehalogenase
(26 Jun 1999)
trans-4-coumaroyl esterase <enzyme> From bacterial and fungal cultures; cleaves coumaric acid from plant cell wall polysaccharides; see also record for feruloyl-4-coumaroyl esterase
Registry number: EC 3.1.1.-
Synonym: trans-p-coumaroyl esterase, p-coumaroyl esterase, p-coumaric acid esterase
(26 Jun 1999)
trans-activation (genetics) Increased rate of gene expression directed by either viral or cellular proteins. These regulatory factors (diffusible gene products) act in trans -- that is, act on homologous or heterologous molecules of DNA. (cis-acting factors act only on homologous molecules.)
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • trans
    °¡·ÎÁú·¯
  • Dalton
    µ¹ÅÏ Çб³(¹Ì±¹MassachusettsÁÖ µ¹ÅÏ ½Ã ¼ÒÀç);µ¹ÅÏ John~(¿µ±¹ÀÇ È­ÇÐ,¹°¸®ÇÐÀÚ)
  • Dalton plan
    µ¹ÅÏ½Ä ±³À°¹ý(¹Ì±¹ MassachusettsÀÇ µ¹ÅÏ ½Ã¿¡¼­ ½Ãµµ,ÇлýÀ» ´É·Â¿¡ µû¶ó ÇнÀ½ÃÅ´)
  • dalton
    ´ÞÅæ(¿øÀÚ Áú·®ÀÇ ´ÜÀ§)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á